In: Accounting
Please answer all question using a full paragraph, watch you grammar and syntax.
a. What is trend in Long Term Debt Paying ability ratios of CVS over the last three years - Explain using ratios and three sentences?
b. What is trend in Long Term Debt Paying Ability ratios of Walgreens over the last three years - Explain using rations and three sentences?
c. Which company has had better Long Term Debt Paying baility ratios over the last 3 years? Explain with ratios and three sentences
CVS
Balance Sheet
All numbers in thousands
Period Ending |
12/31/2017 |
12/31/2016 |
12/31/2015 |
Current Assets |
|||
Cash And Cash Equivalents |
1,696,000 |
3,371,000 |
2,459,000 |
Short Term Investments |
111,000 |
87,000 |
88,000 |
Net Receivables |
13,181,000 |
12,164,000 |
11,888,000 |
Inventory |
15,296,000 |
14,760,000 |
14,001,000 |
Other Current Assets |
945,000 |
660,000 |
722,000 |
Total Current Assets |
31,229,000 |
31,042,000 |
29,158,000 |
Long Term Investments |
- |
- |
- |
Property Plant and Equipment |
10,292,000 |
10,175,000 |
9,855,000 |
Goodwill |
38,451,000 |
38,249,000 |
38,106,000 |
Intangible Assets |
13,630,000 |
13,511,000 |
13,878,000 |
Accumulated Amortization |
- |
- |
- |
Other Assets |
1,529,000 |
1,485,000 |
1,440,000 |
Deferred Long Term Asset Charges |
- |
- |
- |
Total Assets |
95,131,000 |
94,462,000 |
92,437,000 |
Current Liabilities |
|||
Accounts Payable |
15,472,000 |
14,883,000 |
14,319,000 |
Short/Current Long Term Debt |
15,176,000 |
11,367,000 |
8,850,000 |
Other Current Liabilities |
- |
- |
- |
Total Current Liabilities |
30,648,000 |
26,250,000 |
23,169,000 |
Long Term Debt |
22,181,000 |
25,615,000 |
26,267,000 |
Other Liabilities |
1,611,000 |
1,549,000 |
1,542,000 |
Deferred Long Term Liability Charges |
2,996,000 |
4,214,000 |
4,217,000 |
Minority Interest |
4,000 |
4,000 |
7,000 |
Negative Goodwill |
- |
- |
- |
Total Liabilities |
57,440,000 |
57,632,000 |
55,202,000 |
Stockholders' Equity |
|||
Misc. Stocks Options Warrants |
- |
- |
39,000 |
Redeemable Preferred Stock |
- |
- |
- |
Preferred Stock |
- |
- |
- |
Common Stock |
17,000 |
17,000 |
17,000 |
Retained Earnings |
43,556,000 |
38,983,000 |
35,506,000 |
Treasury Stock |
-37,765,000 |
-33,452,000 |
-28,886,000 |
Capital Surplus |
32,079,000 |
31,618,000 |
30,948,000 |
Other Stockholder Equity |
-196,000 |
-336,000 |
-389,000 |
Total Stockholder Equity |
37,691,000 |
36,830,000 |
37,196,000 |
Net Tangible Assets |
-14,390,000 |
-14,930,000 |
-14,788,000 |
Income Statement
All numbers in thousands
Revenue |
12/31/2017 |
12/31/2016 |
12/31/2015 |
Total Revenue |
184,765,000 |
177,526,000 |
153,290,000 |
Cost of Revenue |
156,220,000 |
148,669,000 |
126,762,000 |
Gross Profit |
28,545,000 |
28,857,000 |
26,528,000 |
Operating Expenses |
|||
Research Development |
- |
- |
- |
Selling General and Administrative |
- |
- |
- |
Non Recurring |
- |
- |
- |
Others |
- |
- |
- |
Total Operating Expenses |
- |
- |
- |
Operating Income or Loss |
9,517,000 |
10,366,000 |
9,475,000 |
Income from Continuing Operations |
|||
Total Other Income/Expenses Net |
-208,000 |
-671,000 |
-21,000 |
Earnings Before Interest and Taxes |
9,309,000 |
9,695,000 |
9,454,000 |
Interest Expense |
1,041,000 |
1,058,000 |
838,000 |
Income Before Tax |
8,268,000 |
8,637,000 |
8,616,000 |
Income Tax Expense |
1,637,000 |
3,317,000 |
3,386,000 |
Minority Interest |
4,000 |
4,000 |
7,000 |
Net Income From Continuing Ops |
6,631,000 |
5,320,000 |
5,230,000 |
Non-recurring Events |
|||
Discontinued Operations |
-8,000 |
-1,000 |
9,000 |
Extraordinary Items |
- |
- |
- |
Effect Of Accounting Changes |
- |
- |
- |
Other Items |
- |
- |
- |
Net Income |
|||
Net Income |
6,622,000 |
5,317,000 |
5,237,000 |
Preferred Stock And Other Adjustments |
- |
- |
- |
Net Income Applicable To Common Shares |
6,622,000 |
5,317,000 |
5,237,000 |
Walgreens
Income Statement
All numbers in thousands
Revenue |
8/31/2017 |
8/31/2016 |
8/31/2015 |
Total Revenue |
118,214,000 |
117,351,000 |
103,444,000 |
Cost of Revenue |
89,052,000 |
87,477,000 |
76,691,000 |
Gross Profit |
29,162,000 |
29,874,000 |
26,753,000 |
Operating Expenses |
|||
Research Development |
- |
- |
- |
Selling General and Administrative |
23,605,000 |
23,873,000 |
22,085,000 |
Non Recurring |
- |
- |
- |
Others |
- |
- |
- |
Total Operating Expenses |
- |
- |
- |
Operating Income or Loss |
5,557,000 |
6,001,000 |
4,668,000 |
Income from Continuing Operations |
|||
Total Other Income/Expenses Net |
-11,000 |
-261,000 |
1,248,000 |
Earnings Before Interest and Taxes |
5,546,000 |
5,740,000 |
5,916,000 |
Interest Expense |
693,000 |
596,000 |
605,000 |
Income Before Tax |
4,853,000 |
5,144,000 |
5,311,000 |
Income Tax Expense |
752,000 |
953,000 |
1,032,000 |
Minority Interest |
808,000 |
401,000 |
439,000 |
Net Income From Continuing Ops |
4,078,000 |
4,173,000 |
4,220,000 |
Non-recurring Events |
|||
Discontinued Operations |
- |
- |
- |
Extraordinary Items |
- |
- |
- |
Effect Of Accounting Changes |
- |
- |
- |
Other Items |
- |
- |
- |
Net Income |
|||
Net Income |
4,078,000 |
4,173,000 |
4,220,000 |
Preferred Stock And Other Adjustments |
- |
- |
- |
Net Income Applicable To Common Shares |
4,078,000 |
4,173,000 |
4,220,000 |
Balance Sheet
All numbers in thousands
Period Ending |
8/31/2017 |
8/31/2016 |
8/31/2015 |
Current Assets |
|||
Cash And Cash Equivalents |
3,301,000 |
9,807,000 |
3,000,000 |
Short Term Investments |
- |
- |
- |
Net Receivables |
6,528,000 |
6,260,000 |
6,849,000 |
Inventory |
8,899,000 |
8,956,000 |
8,678,000 |
Other Current Assets |
1,025,000 |
860,000 |
1,130,000 |
Total Current Assets |
19,753,000 |
25,883,000 |
19,657,000 |
Long Term Investments |
6,320,000 |
6,174,000 |
1,242,000 |
Property Plant and Equipment |
13,642,000 |
14,335,000 |
15,068,000 |
Goodwill |
15,632,000 |
15,527,000 |
16,372,000 |
Intangible Assets |
10,156,000 |
10,302,000 |
12,351,000 |
Accumulated Amortization |
- |
- |
- |
Other Assets |
506,000 |
467,000 |
4,092,000 |
Deferred Long Term Asset Charges |
- |
- |
- |
Total Assets |
66,009,000 |
72,688,000 |
68,782,000 |
Current Liabilities |
|||
Accounts Payable |
18,296,000 |
16,690,000 |
15,489,000 |
Short/Current Long Term Debt |
251,000 |
323,000 |
1,068,000 |
Other Current Liabilities |
- |
- |
- |
Total Current Liabilities |
18,547,000 |
17,013,000 |
16,557,000 |
Long Term Debt |
12,684,000 |
18,705,000 |
13,315,000 |
Other Liabilities |
4,223,000 |
4,045,000 |
4,072,000 |
Deferred Long Term Liability Charges |
2,281,000 |
2,644,000 |
3,538,000 |
Minority Interest |
808,000 |
401,000 |
439,000 |
Negative Goodwill |
- |
- |
- |
Total Liabilities |
37,735,000 |
42,407,000 |
37,482,000 |
Stockholders' Equity |
|||
Misc. Stocks Options Warrants |
- |
- |
- |
Redeemable Preferred Stock |
- |
- |
- |
Preferred Stock |
- |
- |
- |
Common Stock |
12,000 |
12,000 |
12,000 |
Retained Earnings |
30,137,000 |
27,684,000 |
25,089,000 |
Treasury Stock |
-9,971,000 |
-4,934,000 |
-3,977,000 |
Capital Surplus |
10,339,000 |
10,111,000 |
9,953,000 |
Other Stockholder Equity |
-3,051,000 |
-2,993,000 |
-216,000 |
Total Stockholder Equity |
27,466,000 |
29,880,000 |
30,861,000 |
Net Tangible Assets |
1,678,000 |
4,051,000 |
2,138,000 |
Solution: | |||||
a) | CVS Long Term Debt Ability Ratios: | 12/31/2017 | 12/31/2016 | 12/31/2015 | |
1) | Times Inetrest Earned | (8268000+1041000)/1041000 | (8637000+1058000)/1058000 | (8616000+838000)/838000 | |
(EBT+Interest Expenses)/Total Interest Expenses | 8.942363112 | 9.163516068 | 11.28162291 | ||
2) | Debt Ratio | (95131000-37691000)/95131000 | (94462000-36830000)/94462000 | (92437000-37196000)/92437000 | |
(Total Assets - Total Equity)/Total Assets | 0.603798972 | 0.610107768 | 0.597607019 | ||
3) | Long-term Debt Ratio | (26792000/95131000) | (31382000/94462000) | (32033000/92437000) | |
Long-term Debt/ Total Assets | 0.281632696 | 0.332218246 | 0.346538724 | ||
4) | Debt-Equity Ratio | (57440000/37691000) | (57632000/36830000) | (55202000/37196000) | |
Total Liabilities/shareholders funds | 1.52397124 | 1.564811295 | 1.48408431 | ||
Explanation: | |||||
The times earned ratio is decreased in last three years | |||||
Debt equity ratio is decreased in last three years | |||||
Long term debt equity ratio is decreased in last three years | |||||
b) | Walgreens Long Term Debt Ability Ratios: | 12/31/2017 | 12/31/2016 | 12/31/2015 | |
1) | Times Inetrest Earned | (4853000+693000)/693000 | (5144000+596000)/596000 | (5311000+605000)/605000 | |
(EBT+Interest Expenses)/Total Interest Expenses | 8.002886003 | 9.630872483 | 9.778512397 | ||
2) | Debt Ratio | (66009000-27466000)/66009000 | (72688000-29880000)/72688000 | (68782000-30861000)/68782000 | |
(Total Assets - Total Equity)/Total Assets | 0.583905225 | 0.588928021 | 0.551321567 | ||
3) | Long-term Debt Ratio | (19188000/66009000) | (25394000/72688000) | (20925000/68782000) | |
Long-term Debt/ Total Assets | 0.290687634 | 0.349356152 | 0.304222035 | ||
4) | Debt-Equity Ratio | (37735000/27466000) | (42407000/29880000) | (37482000/30861000) | |
Total Liabilities/shareholders funds | 1.373880434 | 1.419243641 | 1.214542627 | ||
Explanation: | |||||
The times earned ratio is decreased in last three years | |||||
Debt equity ratio is decreased in last three years | |||||
Long term debt equity ratio is decreased in last three years | |||||
c) | The CVs long term debt ability ratios are better in compare with Walgreens long term debt ability ratios. | ||||
The times earned ratio in 2017 is more in CVS i.e. 8.94. So the payability of the company is better. Also the long term debt is more in | |||||
The balance in debt ratio is also better in CVS and it helps to maintain the balance in financial leverage as well. | |||||